Early Improvement in Prurigo Nodularis With IL-31 Antagonist Maintained at 1 Year

(MedPage Today) -- SAN DIEGO -- More than two-thirds of patients with prurigo nodularis obtained long-term relief from itching, skin lesions, and sleep disturbance with the interleukin (IL)-31 antagonist nemolizumab, according to the largest...
Source: MedPage Today Dermatology - Category: Dermatology Source Type: news